Loading stock data...

Choksi Laboratories Limited

BSE: CHOKSILA

BSE
109.85 6.30 (6.08%)

Prev Close

103.55

Open Price

105

Volume

1,148

Today Low / High

104.05 / 113.9

52 WK Low / High

95 / 236.7

Range

104 - 115

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 109.85, reflecting a change of 6.3 (6.08402%). The expected target range on the BSE is 104 - 115. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

25 Feb 105.00 4.62%
24 Feb 108.70 -4.74%
23 Feb 109.00 -0.32%
20 Feb 109.00 0.05%
19 Feb 114.95 -3.48%
18 Feb 115.45 -0.39%
17 Feb 113.30 2.38%
16 Feb 120.00 -3.67%
13 Feb 115.00 -3.35%
12 Feb 124.95 -3.36%
11 Feb 119.75 -2.30%
10 Feb 116.25 3.14%
09 Feb 126.80 -8.32%
06 Feb 118.75 -1.47%
05 Feb 122.00 -4.59%
04 Feb 122.00 -2.05%
03 Feb 120.40 1.29%
02 Feb 121.00 -0.50%
01 Feb 119.95 0.88%
30 Jan 110.60 7.91%
29 Jan 114.55 1.35%
28 Jan 116.00 -2.37%

Choksi Laboratories Limited Graph

Choksi Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Choksi Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 109.85, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 109.85 110.95 99.85 - 122.04
112.05 89.64 - 134.46
113.15 79.20 - 147.09
Bearish Scenario 109.85 108.75 97.88 - 119.63
107.65 86.12 - 129.18
106.55 74.59 - 138.52

Overview of Choksi Laboratories Limited

ISIN

INE493D01013

Industry

Specialty Business Services

Vol.Avg

4,643

Market Cap

765,134,141

Last Dividend

0

Official Website

Visit Website

IPO Date

2002-01-02

DCF Diff

-114.05

DCF

223

Financial Ratios Every Investor Needs

Stock Rating Details for CHOKSILA

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 41.78 Cr 7.19 Cr 34.59 Cr 0.8280 0.00 Cr 1.22 Cr 4.80 Cr 1.52 Cr 2.19 11.30 Cr 0.0365
2024-03-31 36.70 Cr 3.72 Cr 32.97 Cr 0.8985 0.00 Cr 1.05 Cr 4.57 Cr 1.11 Cr 1.59 10.38 Cr 0.0302
2023-03-31 34.44 Cr 3.38 Cr 31.06 Cr 0.9018 0.00 Cr 0.99 Cr 4.80 Cr 3.21 Cr 4.61 12.73 Cr 0.0932
2022-03-31 30.04 Cr 2.83 Cr 27.21 Cr 0.9058 0.00 Cr 0.75 Cr 3.55 Cr 0.21 Cr 0.30 9.02 Cr 0.0069
2021-03-31 25.69 Cr 3.51 Cr 22.18 Cr 0.8634 0.00 Cr 0.73 Cr -0.30 Cr -2.61 Cr -3.74 4.59 Cr -0.1015

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.61 Cr 65.33 Cr 41.73 Cr 23.6048 Cr 29.16 Cr 28.54 Cr 0.56 Cr 47.13 Cr 0.00 Cr 0.00 Cr 0.45 Cr 23.8752 Cr
2024-03-31 0.66 Cr 61.95 Cr 39.74 Cr 22.2106 Cr 30.87 Cr 30.22 Cr 0.36 Cr 46.07 Cr 0.23 Cr 0.00 Cr 0.25 Cr 18.8476 Cr
2023-03-31 0.34 Cr 60.36 Cr 39.26 Cr 21.1084 Cr 32.42 Cr 32.08 Cr 0.21 Cr 44.75 Cr 0.20 Cr 0.00 Cr 0.09 Cr 12.5142 Cr
2022-03-31 0.41 Cr 64.42 Cr 46.51 Cr 17.9026 Cr 37.29 Cr 36.88 Cr 0.25 Cr 47.91 Cr 0.24 Cr -0.74 Cr 0.35 Cr 15.5235 Cr
2021-03-31 0.31 Cr 66.38 Cr 48.63 Cr 17.7462 Cr 39.15 Cr 38.84 Cr 0.11 Cr 50.54 Cr 0.46 Cr -0.58 Cr 0.35 Cr 16.2201 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 11.7780 Cr -7.6050 Cr -4.2176 Cr 4.0911 Cr -0.0446 Cr 0.6123 Cr -7.4393 Cr 2.1533 Cr -1.0508 Cr 0.0000 Cr -0.1934 Cr
2024-03-31 11.5515 Cr -6.6484 Cr -4.5837 Cr 4.5470 Cr 0.3194 Cr 0.6569 Cr -7.0947 Cr 1.1098 Cr -1.1133 Cr 0.0000 Cr -0.1547 Cr
2023-03-31 8.2538 Cr -0.7084 Cr -7.6149 Cr 4.1031 Cr -0.0696 Cr 0.3375 Cr -4.1507 Cr 3.7214 Cr -4.4073 Cr 0.0000 Cr 0.0414 Cr
2022-03-31 7.8774 Cr -2.7088 Cr -5.0676 Cr 5.0148 Cr 0.1010 Cr 0.4071 Cr -2.8626 Cr 0.3670 Cr -1.4492 Cr 0.0000 Cr -0.1384 Cr
2021-03-31 5.8984 Cr -7.6469 Cr 1.6291 Cr -2.1987 Cr -0.1194 Cr 0.3061 Cr -8.0971 Cr -2.8081 Cr 4.7267 Cr 0.0000 Cr 0.0650 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 10.82 Cr 8.72 Cr 2.10 Cr 0.1945 0.80 Cr 0.31 Cr 0.45 3.55 Cr 0.0287
2025-09-30 11.12 Cr 1.79 Cr 9.33 Cr 0.8391 1.24 Cr 0.24 Cr 0.35 2.94 Cr 0.0218
2025-06-30 11.24 Cr 1.97 Cr 9.27 Cr 0.8245 1.23 Cr 0.39 Cr 0.55 2.90 Cr 0.0342
2025-03-31 11.40 Cr 1.65 Cr 9.75 Cr 0.8553 1.86 Cr 0.92 Cr 1.32 3.55 Cr 0.0808
2024-12-31 10.38 Cr 1.96 Cr 8.43 Cr 0.8116 0.87 Cr 0.11 Cr 0.15 2.55 Cr 0.0102

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.31 Cr 0.04 Cr 0.35 Cr 12.17 Cr 0.34 Cr 17.62 Cr 45.77 Cr 65.24 Cr 40.74 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -23.60 Cr
2025-03-31 0.61 Cr 0.12 Cr 0.73 Cr 11.27 Cr 0.56 Cr 16.32 Cr 47.13 Cr 65.33 Cr 41.73 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -23.01 Cr
2024-09-30 0.22 Cr 0.10 Cr 0.32 Cr 10.51 Cr 0.65 Cr 15.76 Cr 47.00 Cr 64.01 Cr 40.99 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.92 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Specialty Business Services

Company Name Symbol Price Market Cap Volume
Sundaram Finance Holdings Limited SUNDARMHLD ₹684.25 ₹151,973,285,973.00 ₹147,640.00
BLS International Services Limited BLS ₹290.20 ₹119,462,387,794.00 ₹1,908,800.00
CMS Info Systems Limited CMSINFO ₹298.50 ₹49,095,053,489.00 ₹1,517,419.00
PDS Limited PDSL ₹303.95 ₹42,923,545,749.00 ₹119,117.00

Key Executives

Company Secretary & Compliance Officer
Prakhar Dubey

Gender: male

Year Born:

Chief Executive Officer, MD & Executive Chairman
Sunil Kumar Choksi

Gender: male

Year Born: 1955

Chief Financial Officer & Whole-Time Director
Vyangesh Choksi

Gender: male

Year Born: 1979

Chief Operating Officer & Whole Time Director
Himika Choksi Varma

Gender: female

Year Born: 1976

Whole-Time Director
Stela Choksi

Gender: female

Year Born: 1956

FAQs about Choksi Laboratories Limited

Who is the CEO of the company?

The CEO is Sunil Kumar Choksi.

What is the current market price of the stock?

The current price is ₹109.85.

What is the 52-week price range?

The range is ₹95-236.7.

What is the market capitalization of the company?

The market capitalization is ₹76.51 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 41.16.

Which sector does the company belong to?

The company operates in the Industrials sector.

What does the company do?

Overview of Choksi Laboratories Limited (ISIN: INE493D01013) is a leading Specialty Business Services in India. With a market capitalization of ₹76.51 crores and an average daily volume of 4,643 shares, it operates in the Specialty Business Services. The company last declared a dividend of ₹0.